DME (psychedelic)
From Wikipedia, the free encyclopedia
| DME (psychedelic) | |
|---|---|
.png/200px-DME_(psychedelic).png) |
|
 |
|
| IUPAC name | 2-Amino-1-(3,4-dimethoxy-phenyl)-ethanol |
| Other names | 3,4-Dimethoxy-beta-hydroxyphenethylamine 3,4-Dimethoxy-1-ethyl-(beta-hydroxy)amine |
| Identifiers | |
| CAS number | |
| SMILES | COc1cc(ccc1OC)C(O)CN |
| Properties | |
| Molecular formula | C10H15NO3 |
| Molar mass | 197.23 g/mol |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references |
|
DME, or 3,4-dimethoxy-beta-hydroxyphenethylamine, is a lesser-known psychedelic drug. It is the beta-hydroxy analog of DMA. DME was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 115 mg, and the duration unknown. DME produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of DME.
[edit] See also
[edit] External links
 |
This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |
